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How Cellular Metabolic States Affect the Spontaneous Formation of Yeast Prions

Overall Aim
My overall aim is to determine how cellular metabolic state can influence spontaneous
prion formation rates in baker’s yeast (Saccharomyces cerevisiae) with or without the Hsp104
chaperone protein present.

Specific Aim 1
We will determine if yeast cells in different phases, i.e. in their growth cycle, such as the
exponential phase, the stationary phase, and the declining phase, show spontaneous prion
formation rates that are significantly different from one another.

Specific Aim 2
We will determine if spontaneous prion formation rates are different in the KB104 yeast
strain lacking the Hsp104 chaperone protein and the PC301u yeast strain containing the Hsp104
chaperone protein, which is known to play a role in facilitating prion propagation [9]. We will
compare rates between straits across different phases of the yeast growth cycle.

Background Information
Prions, in general, are transmissible misfolded, pathogenic proteins that can induce
abnormal folding of properly folded versions of themselves [2]. Specifically, prions are
misfolded infectious self-aggregating proteins in mammals that are associated with
neurodegenerative diseases which result in transmissible spongiform encephalopathy such as
Creutzfeld-Jacob disease [4,15]. Creutzfeld-Jacob Disease is a fatal neurodegenerative human
disease that progresses due to the abnormal formation of a prion protein aggregate [4,15].
Several non-human diseases such as Mad Cow Disease, Chronic Wasting Disease and Scrapie
result from misfolded proteins as well. Many farmers’ livestock have been affected by
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pathogenic prions resulting in livestock being culled [3]. Any knowledge gained in
understanding pathogenic prions function will be a significant step in understanding how they
evolved into degenerative neural diseases and could lead to treatments that lessen the effects
pathogenic prions have on human and animal lives [14].
PRNP is the mammalian gene that encodes the prion protein (PrP) which is found on the
surface of numerous cell types [2]. PrP was the first protein discovered that misfolds and
aggregates. Later, it was discovered that other proteins do this, so now the term prion is
associated with any protein that misfolds into an infectious and self-aggregating form [14]. In
mammals, proteins that can misfold into prions are found primarily in the brain and can cause
neuronal death when converted to their pathogenic prion form [7]. These misfolded proteins can
lead to brain damage when they induce normal cellular versions of themselves to alter their
conformation [6]. Prions are a physiological issue due to their ability to induce chain reactions
that resulted in the accumulation of large numbers of aberrant structures when they interact with
properly folded prion proteins) [8, 10]. Yet, the most dangerous feature of pathogenic prions is
that they are extremely difficulty to eradicate. To eradicate them, their protein structure must be
denatured to make them nonfunctional. Some cellular process appears to eradicate misfolded
prions, and most of the cellular processes capable of this have been found in yeast models that
involve chaperone proteins [7].
We will use baker’s yeast, Saccharomyces cerevisiae, as our model organism. Baker’s
yeast is also easy to acquire, grow in a laboratory setting. It can produce many colonies in a short
time, and there is extensive knowledge available on baker’s yeast (S. cerevisiae possesses)
proteins that can spontaneously misfold and act as pathogenic prions [5]. These prions act on a
molecular level exactly like mammalian prions and misfo ld and self-aggregate into amyloid
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fibers, just like prions in mammals [9]. (The prions in baker’s yeast are passed on to daughter
cells when the yeast cells divide) [13]. These prions cannot be transferred to humans making
them completely safe to work with [15]. One of these yeast proteins that misfolds into a prion
state is the Ure2 protein (which we have chosen to examine). Therefore, Saccharomyces
cerevisiae is an appropriate model organism to study spontaneous prion formation rates with. In
addition, understanding the formation, propagation, treatment, and eradication of pathogenic
prions in yeast will improve our, understanding of how these activities occur in mammals [6].
The URE2 yeast gene encodes the Ure2 protein. The Ure2 is a functional protein that binds the
ammonium ion (NH4 +) in cells and is involved in nitrogen-sensing [7]. The Ure2 protein can
misfold into the infectious prion referred to as [URE3]. (In yeast, wildtype genes are usually
written in all-caps and proteins are written with only the first letter capitalized, but the misfolded,
prion version of the Ure2 protein is written in all-caps and with square brackets. This prion
nomenclature is confusing but reflects the fact that the prion state was initially only partially
understood as an epigenetic change to the cells [5]. It wasn’t until after its nomenclature had
been established that it was discovered that [URE3] was the prion form of the Ure2 protein [6].)
The [URE3] state of the Ure2 protein is non-functional and no longer able to participate in
nitrogen sensing; however, the [URE3] prion will convert all Ure2 proteins it interacts with
within the cell into additional infectious [URE3] prions [4]. [URE3] prions will not kill the cell
nor dramatically alter its growth cycle. Some research has suggested that the [URE3] prion might
be deleterious to yeast cells and might slow down their growth [5]. This is uncertain; while it is
certain that, once present, [URE3] will convert all the Ure2 proteins in the cell into [URE3]
prions [2, 3, 8].
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Chaperone proteins function by assisting other proteins to fold correctly, unfold for
degradation, or unfold and refold into their correct conformation [3]. Previous research has
established that chaperone proteins can influence how well already-established prions propagate
[15]. Chaperone proteins are always present in cells, but their synthesis levels respond to cellular
stress [6]. Some conditions that stress the cells, which usually lead to higher instances of protein
misfolding, will increase expression of most chaperone proteins [2].
Metabolic states are biochemical processes that occur within living cells that consists of
different rates of the catabolism and anabolism of molecules [11]. The exponential phase is a
metabolic state when cell division and cell proliferation is occurring rapidly. The static or
stationary phase is a metabolic state when there is only slow cell division and the rate of cell
division is about equal to the rate of cell death. The declining phase is a metabolic state when
there is little or no cell division as a result of cells dying.
Synthetic complete defined medium (SCD) is a minimal medium that contains all the
specific nutrients the yeast need to grow, but it contains no extra nutrients. Ureidosuccinic acid
(USA) in the medium is required by uracil-deficient cells to synthesize uracil and grow. SCD +
NH4 + + USA medium does not support the growth of cells defective in uracil synthesis that
express the functional Ure2 protein [9]. In the presence of (NH4 +), functional Ure2 proteins
inhibit the expression of the transporter protein required to facilitate the entry of USA into the
cells [6]. Without USA, uracil(-) cells cannot synthesize uracil, and as a result of this, they will
not grow. That is, prion-free cells defective in uracil biosynthesis with functional Ure2 proteins
are unable to make uracil using the USA medium and do not grow. Yeast cells containing the
[URE3] prion lack functional Ure2 proteins and are able to grow on SCD + NH 4 + + USA
medium and are able to utilize USA for synthesis of uracil [7]. In summary, in SCD + NH4 + +
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USA medium, cells defective in uracil biosynthesis without the [URE3] prion present do not
grow, but cells defective in uracil biosynthesis with the [URE3] prion present do grow. All the
cells we used in these experiments are defective in uracil biosynthesis [6]. Therefore, SCD +
NH4 + + USA can be used as a selective medium to identify and quantify cells containing the
[URE3] prion.

Experimental Approach
Specific Aim 1
Our hypothesis is to determine how cellular metabolic state can influence spontaneous
prion formation rates in baker’s yeast (Saccharomyces cerevisiae). We predict that different
metabolic states will influence the rates at which prions spontaneously form. We also predict that
yeast cells at different phases in their growth cycle, such as the exponential phase, the stationary
phase, and the declining phase, will show spontaneous prion formation rates that vary
significantly from one another because of their being in different metabolic states and possessing
varied levels of numerous effector proteins. We will start with cultures of prion-free yeast and
grow them in the nutrient-rich YPD medium. This medium is a defined medium consisting of
yeast extract, peptone, and dextrose (hence YPD) that contains all the nutrients required for
growth, reproduction, and survival. A small fraction of cells will spontaneously form prions, but
both both prion-free and prion-containing yeast will readily grow in YPD.
We will take samples of the yeast from the YPD medium at the exponential, stationary,
and declining phases of growth. These isolates will be plated at a value of one million (10 6 ) yeast
cells on the SCD + NH4 + + USA medium and the number of colonies that grow will be counted.
Since only prion-containing cells grow on SCD + NH4 ++ USA, the number of colonies that grow
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will indicate how many individual yeast cells out of the original one million spontaneously
converted to the prion state by having their Ure2 proteins misfold into [URE3].
We will then calculate the spontaneous [URE3] prion formation rate in these cells by
dividing the number of CFUs on the SCD + NH4 ++ USA plates by the number of cells originally
plated. That is, spontaneous [URE3] formation rate is defined as the fraction of cells that have
their Ure2 proteins spontaneously misfold into the [URE3] prion state without having an outside
[URE3] prion introduced to them.
We will obtain and compare spontaneous [URE3] prion formation rates for cells in three
different metabolic states – exponential phase, stationary phase, and declining phase of cell
growth.
We predict that spontaneous prion formation rates will be highest in the declining phase
of yeast growth as a result of the cultures being deficient in nutrients. In this stressful
environment, the PC301u cells will produce more chaperone proteins and other proteins involved
in protein folding and misfolding and will be more likely to generate prions.
Specific Aim 2
We will use two yeast strains, PC301u and KB104 that are both prion-free. Both strains
are deficient in uracil synthesis, so that growth on SCD + NH4 + + USA plates can be used as a
marker for the presence of the [URE3] prion. The two strains are genetically identical except that
KB104 has had its HSP104 gene deleted and PC301u retains that HSP104 gene. [5].
Previous research has established that the Hsp104 protein aids [URE3] prion propagation in cells
that already contains prions, which is why we chose to focus on the contribution of this specific
chaperone protein [6]. If chaperone protein levels are affecting the rates of spontaneous prion
formation, we hypothesize that Hsp104 will be one of the chaperones playing a role. In cells
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lacking the Hsp104 protein, we hypothesize that we will see altered rates of spontaneous
formation at each phase of cell growth compared to cells with functional Hsp104. This will also
provide insight on how Hsp104 proteins and metabolic states interact to influence the rates of
spontaneous prion formation in S. cervesaie cells.
Both strains (PC301u expressing Hsp104 chaperone protein and KB104 unable to express
Hsp104) will be initially free of any prions. Both will grow readily in YPD medium, which
supports growth of both prion-free cells and cells that spontaneously form the [URE3] prion.
During incubation, we expect that about one in every 100,000-yeast cell should spontaneously
convert Ure2 protein to [URE3] prion [6]. To identify and quantify the few rare cells that contain
the [URE3] prion, one million cells will be isolated from the culture at the 4, 8, 24, 72, and 100
hours and plated on SCD+ NH4 ++ USA medium [8]. Yeast colonies that grow on the SCD+
NH4 ++ USA medium will then be counted. The rate of spontaneous formation at each growth
phase assayed can be calculated as the number of colonies divided by the total number of cells
that were originally plated. This experiment will be repeated a total of four times and the average
taken for the spontaneous prion formation rates during the three different metabolic states.
Hsp104 does not cause prions but in its presence prion proteins are more likely to occur. As a
result, we expect the spontaneous prion formation rate to be lower during the exponential growth
phase in the KB104 yeast strain (which lacks the Hsp104 protein) than in the PC301u strain that
contains Hsp104. In this environment, the KB104 cells should be less likely to convert their
proteins into prions because the cells have ample nutrients in a non-stressful environment and the
Hsp104 chaperone.
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Methodology
YPD plates of KB104 and PC301u cultures were taken out of the cold room. One colony
of each was placed in a test tube containing 5mL of YPD liquid medium and placed in the
incubator overnight. After overnight growth, cell concentrations were calculated using the TC10
cell counter from BioRad. KB104 and PC301u were each diluted to a concentration of 5 x 10 5
c/mL in 5 mL of YPD and then placed in a New Brunkswick Innova shaking incubator at 30 C.
Cell counts were performed on a BioRad TC10 Counter as follows. Ten microliters of diluted
cells were pipetted onto the TC10 slide and the number of cells were counted by the machine
which reported the count in cells/mL. Original cell concentration was calculated as TC10 count *
dilution factor.
Cells were collected from the YPD medium at the exponential, stationary, and declining
phases of growth at 4, 8, 20, and 100 hours post inoculation to determine spontaneous [URE3]
prion formation rates. Cell concentration at each time point was determined using the TC10
counter.
The volume of each culture needed to give 10 6 cells was calculated from the cell count
determined above. The appropriate volume of cells was placed in an eppendorf micro-centrifuge
tube and spun for 1 minute in a Fisher AccuSpin micro-centrifuge. The supernatant was aspirated
off, 100µL of deionized water was added to the micro-centrifuge tube, and the pellet was resuspended gently with pipetting. The solution was spread on SCD + NH4 + + USA agar plates
with a glass hockey stick. Each plate was labeled with the strain, incubation time, and the
number of cells plated. The SCD + NH4 ++ USA agar plates were then placed in a Fisher
incubator for seven days at 30°C. To quantitate spontaneous prion formation rates, the number of
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colonies that grew on SCD+ NH4 ++ USA agar plates were divided by the total number of cells
plated.
Results
Prion protein concentration is a key factor for prion propagation of yeast prions and is
dependent on the expression levels of a number of molecular chaperones [9]. Hsp104 has been
shown to play a significant role in prion propagation in yeast [4]. Hsp104 has a bystander effect
assisting prion propagation when they are present, while also seeming to reduce the rate at which
the first prion proteins spontaneously mis-fold [4,13]. As shown in figure 1, when cells lack the
Hsp104 chaperone protein, their rate of spontaneous prion formation after 20 hours of growth is
significantly higher than when Hsp104 is present. Preliminary results at other time points suggest
that in the absence of Hsp104, the spontaneous generation rates of prions are more stable at time
points prior to 20 hours. Due to bacterial contamination of the PC301u strain during our
experiments, a repeat of the PC301u experiments needs to be conducted to determine if
spontaneous prion formation rates are consistently higher in the KB104 yeast containing strains.
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Figure 1: Spontaneous prion formation rates are the lowest in the first 20 hours and the highest
after 20 hours in the KB104 strain lacking the Hsp104 gene (labeled Δhsp104 on the graph.) The
two strains used were PC301u, labeled wt+ on the graph as it is wildtype, and KB104, labeled
Δhsp104 on the graph as it has had the HSP104 chaperone protein gene deleted.
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Figure 2: There is no significant difference in the growth rates of the KB104 (labeled Δhsp104)
and PC301u (labeled wt+) yeast strains. This suggest that the Hsp104 chaperone protein does not
affect the yeast strains growth rates.
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Discussion
In both yeast strains, the exponential growth phase ended post 21 hours and the stationary
phase lasted for approximately 48 hours. The cultures reached their maximum growth rate at
approximately 70 hours. At this time point, the yeast cells entered their declining phase. In both
strains, the declining phase was not documented because of time restraints and some bacterial
contamination problems. I was unable to collect all the data I originally intended to collect.
Additionally, we believed that the TC10 Counter was counting yeast cells present whether dead
or alive, which made the data difficult to interpret. To address this problem, we started mixing
the dilution factor with trypan blue, which stains dead cells blue thus allowing us to get an
accurate count of the cells that are dead versus those still alive. However, the TC10 Counter
reported that only nine to eleven percent of the cells are viable or alive. This needs to be
investigated further. Counts can be done manually with a hemocytometer, using cells in the
presence and absence of trypan blue. We can do a visual count of live versus dead. We might
also use a spectrophotometer to get a total cell count. We will then compare living and dead cell
proportions using these various methods.
The preliminary results in Figure 1 show that metabolic states do appear to affect rates of
spontaneous prion formation. Samples taken during the first 20 hours were in the exponential
phase of growth. These cells had a lower rate of spontaneous prion formation than in stationary
and lagging phases of growth (beyond the 20-hour mark). We only had data for this comparison
in the cells lacking the Hsp104 protein, but if cells lacking the Hsp104 protein had different rates
of spontaneous [URE3] prion formation in different metabolic states, we expect to see the same
pattern in cells which express the Hsp104 protein, although this will need to be confirmed.
Certainly Figure 2 shows that the lack of the Hsp104 protein appears to have no effect on growth
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rates of yeast when compared to an identical strain expressing Hsp104. That is, the absence of
Hsp104 does not affect the metabolic states of the yeast so dramatically as to alter its pattern of
growth rates.
During the experiments, some of the PC301u cultures got contaminated with bacteria. We
could not collect spontaneous prion formation data from those cultures, and time ran out before
we could re-do those experiments. The lack of data due to these contamination problems meant
could not do a proper comparison of spontaneous [URE3] prion formation rates in cells
expressing the Hsp104 protein to those lacking the Hsp104 protein. Figure 1 shows we only have
spontaneous [URE3] prion formation rate data for the PC301u cells with Hsp104 protein during
exponential phases of growth. As a result, we cannot yet conclude if presence of Hsp104
contributes to or hinders spontaneous [URE3] prion formation rates in the stationary or declining
phases of growth.
Future Directions
The PC301u yeast strain in some of our experiments was contaminated by bacteria. This
contamination is the reason why there are no data points available for PC301u past the 20-hour
mark. Antibiotics are not traditionally used in yeast cultures, but if bacterial contamination
persists, a commonly used antibiotic like ampicillin may be added in future experiments.
Because of time restrictions, we were not able to evaluate if the low levels of our yeast cells’
viability has anything to do with the rate of spontaneous prion formation. Furthermore, more
research can be done on documenting what happens to prion formation rates in yeast cells when
they are put into a stressful environment such as lack of nutrients during exponential phases of
growth. Future studies can measure Hsp104 levels at different time during growth to see if there
is any correlation between Hsp104 levels and spontaneous prion formation rates. Future studies
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can also investigate spontaneous prion formation levels in strains with different chaperone
proteins knocked out.
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